UnitedHealth Group Inc.’s UNH health service segment UnitedHealthcare is likely to have performed well in the third quarter, which may reflect on the quarterly results, slated for release on Oct 15.
UnitedHealthcare benefits business has been a major contributor to the company’s top-line growth.
In the last reported quarter, revenues from UnitedHealthcare grew 6.1% year over year. Revenue growth was driven by higher enrollment and increase in pricing. All the business groups – Employer and Individual, Medicare and Retirement and Community and State contributed to the growth. Earnings from operations were up 12.1% year over year to $2.6 billion, led by revenue growth and cost control.
Click here to know how the company’s overall third-quarter performance is expected to be.
Let’s Delve Deeper
UnitedHealthcare has consistently witnessed balanced growth, serving increasingly diverse markets. Among these growing market segments are Medicaid, including people needing long-term services and support and dual eligible individuals; seniors, including Medicare Advantage and Part D plans, as well as employer sponsored retiree groups; large national employers, along with medium and small employer groups; and emerging markets, like global health benefits, social services, personalized wellness and caregiver services.
The segment is likely to have seen an increase in membership in the third quarter, primarily as a result of acquisitions and growth in services to self-funded employers and seniors.
Within UnitedHeathcare, fee-based commercial group business should have benefitted from an acquisition.
Revenues from Medicare Advantage business is likely to show an increase due to growth in people served through individual and employer-sponsored group Medicare Advantage plans.
UnitedHealthcare Community & State revenues should have gained from growth in people served with higher acuity needs.
The segment’s operating earnings should have benefitted from operating cost management.
Zacks Rank & Key Picks
Currently, UnitedHealth carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader healthcare sector include Molina Healthcare, Inc. MOH, Cigna Corp. CI and HCA Healthcare, Inc. HCA. While Molina sports a Zacks Rank #1 (Strong Buy), Cigna and HCA Healthcare carry a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth for Molina Healthcare, Cigna and HCA Healthcare is currently projected at 9.6%, 11.7% and 11.3%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cigna Corporation (CI) : Free Stock Analysis Report
Molina Healthcare, Inc (MOH) : Free Stock Analysis Report
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research